openPR Logo
Press release

Antivirals Market - Positive long-term growth outlook 2016 - 2024

12-28-2017 11:13 AM CET | Health & Medicine

Press release from: Transparency Market Research

/ PR Agency: Transparency Market Research
Antivirals Market - Positive long-term growth outlook 2016 -

An antiviral is an agent that eliminates a virus or restrains its ability to multiply and hence, prevents it from replicating and reproducing. Antiviral drugs are used in the treatment of lethal viral infections such as HIV, hepatitis B and C viruses, influenza A and B viruses, and herpes viruses. According to WHO, 36.7 million people were living with HIV at the end of 2015.

Browse Premium Industry Research Report with Analysis: https://www.transparencymarketresearch.com/antivirals-market.html

Although the development of antivirals has lagged behind that of antibiotics, the report finds that this sector is presented with vast unmet medical needs and substantial profits for drug candidates who invest in the production of new antiviral drugs. As a result, the number of biotechnology companies focusing on R&D activities for advanced antivirals is second only to cancer. According to the report, the global market for antivirals is expected to expand at a moderately healthy CAGR during the forecast period of 2016 to 2024.

Some of the primary trends in the global market for antivirals are the development of new mechanisms and research on second-generation molecules, combination therapies, and topical administration routes. Investors proactively pursue research and development of drug candidates for viral diseases that require long-term treatment. They also prefer initiatives that have a predominant patient-base in developed regions of the world and are readily accepted by physicians and drug formularies. Antivirals ideally fit the profile and hence are gaining strong investments. Moreover, the need to improve the quality of life of the patients on the available antiviral regimens is encouraging efforts for the development of second-generation molecules, such as IFN-α.

Request for Sample Copy of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2306

Several patent expiries are expected during the forecast period of the report, such as Sustiva, Tamiflu, Tenofovir, Combivir, Telbivudine, and Relenza. The report expects the patent expiries of these blockbuster drugs will trigger the development of generic therapeutics in the global antivirals market and make it more competitive. Pipeline drugs such as Rilpivirine, Elvitegravir, Vicriviroc, and Rapiacta are expected to positively impact the market upon arrival.

Some of the other factors driving the global market for antivirals are the increase in healthcare infrastructure spending not only in developed countries but also among emerging economies, the rising prevalence of life-threatening viral diseases, and an increase in public awareness. Conversely, the high cost of R&D and stringent government policies are expected to hinder the growth of the global market for antivirals.

On the basis of products, the global market can be segmented into antivirals for hepatitis-C, hepatitis-B, HIV, herpes, influenza, and others. The market can also be segmented on the basis of enzyme specific actions, such as DNA polymerase inhibitors, reverse transcriptase inhibitors, NS3 Protease inhibitors, and others.

Geographically, the global market for antivirals can be segmented into North America, Europe, Asia Pacific and Rest of the World. The report points out that the U.S. is the most prominent market for antiviral drugs, dominating the North American region with a strong healthcare infrastructure and the presence of several prominent players. The U.K. leads in the European market while Japan is a significant market in Asia Pacific. Several countries in Asia Pacific and Africa are expected to grow at a robust rate during the forecast period of 2016 to 2024.

Some of the key players currently operational in the global market for antivirals are Abbott Laboratories, GlaxoSmithKline, plc, BoehringerIngelheim Corporation, AstraZeneca AB, Novartis International AG, Merck and Co. Inc., and Johnson & Johnson.

Pre Book this Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=2306<ype=S

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact us:

Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Antivirals Market - Positive long-term growth outlook 2016 - 2024 here

News-ID: 878483 • Views: 116

More Releases from Transparency Market Research

Wearable EEG Devices Market: Growing incidences of Neurovascular Disorders is Dr …
According to new market research titled 'Wearable EEG Devices Market to 2027 - Global Analysis and Forecasts by Channel and Application.' The global wearable EEG devices market is expected to reach US$ 1,556.35 Mn in 2027 from US$ 745.05 Mn in 2018. The market is projected to grow with a CAGR of 8.7% from 2019-2027. The report provides trends prevailing in the global wearable EEG devices market and the factors
Decentralized Electricity Generation Market - Global Industry Analysis, Share, G …
Global Decentralized Electricity Generation Market: Overview With the increasing installation of smart grids and the rising number of electricity generation resources, the power generation industry has been undergoing a significant change over the recent past. The modification in the grid structure, which permits decentralization of electricity generation, is acting as the main driving force behind the substantial growth of the global market for decentralized electricity generation. The main objective of this research
Global Sucralose Market Outlook In The Developed And Emerging Industry
Sucralose Market Overview Sugar substitute market is witnessing an increasing demand driven by the increasing sales of various sugar substitutes such as natural sweeteners and artificial sweeteners. Sucralose, an artificial sweetener used as a sugar substitute is highly preferred by consumers owing to its zero calorie attribute. Though sucralose is 600 times sweeter than sugar but interestingly it is not identified as the carbohydrate by the human body. Sucralose has its
Flavored Syrup Market - Growth Powered with Latest Development Scenario & Influe …
Flavored Syrup Market Introduction Global syrup market is witnessing a significant demand generated by the food and beverage industry. Consumers' increasing preference for different and personalized flavors in food has driven the syrup manufacturers to produce a wide range of flavored syrups. Flavored syrups contain artificial or natural flavorings mixed along with sugar and water. Obtain Report Details @ https://www.transparencymarketresearch.com/flavored-syrup-market.html Increasing demand of flavored syrups especially among the consumers contributes to the

All 5 Releases


More Releases for Antiviral

Asia Pacific Antiviral Drug Market – Trends, Growth & Forecasts (2018 – 2024 …
Summary of the Report: “Asia Pacific Antiviral Drug Market study by Envision Inteligence discusses in detail about diverse market dynamics influencing the market and covers the leading market players and competitive highlights and trends prevailing over the years". The report "ASIA PACIFIC ANTIVIRAL DRUG MARKET," is expected to reach USD XX Billion by the year 2024, at a CAGR of 4.99% during forecast period. Antiviral Drugs are medicines which are used for
North America Antiviral Drug Market – Trends, Growth & Forecasts (2018 – 202 …
The report "NORTH AMERICA ANTIVIRAL DRUG MARKET," is expected to reach USD XX Billion by the year 2024, at a CAGR of XX% during forecast period. Antiviral Drugs are medicines which are used for treating viral infections. Most anti-viral drugs are used for particular viral infections, similar to antibiotics, while a broad-spectrum anti-viral drug is effective against a varied range of viruses. Antiviral drugs do not kill their target pathogen,
Europe Antiviral Drug Market – Trends, Growth & Forecasts (2018 – 2024)
The report "EUROPE ANTIVIRAL DRUG MARKET," the Europe Antiviral Drug market is expected to reach USD XX Billion by the year 2024, at a CAGR of 4.99% during forecast period. Antiviral Drugs are medicines which are used for treating viral infections. Most anti-viral drugs are used for particular viral infections, similar to antibiotics, while a broad-spectrum anti-viral drug is effective against a varied range of viruses. Antiviral drugs do
Antiviral Immunoglobulin Market to Incur Rapid Extension During 2027
Immunoglobulin's also called as Antibodies are large Y-shaped protein produced by B-cell. These are the glycoprotein molecule produced by plasma cells in response to entry of foreign entity such as bacteria and viruses in the body. Antiviral immunoglobulin is used for the prevention of lower respiratory tract infections, prevention of re-infection with HCV, treatments of diseases caused by the vaccinia virus, treatment of rare adverse reactions to smallpox vaccination,
Antiviral Drugs Market Research Report by Key Players Analysis 2024
The global antivirus drugs market is likely to exhibit a solid CAGR of 6.40% between 2016 and 2024. The market’s valuation is expected to rise from US$48.3 bn to US$82.9 bn over the forecast period. The global antiviral drugs market is segmented by region into North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Developed countries in North America and Europe are likely to play a key
North America Antiviral Drugs Market - Preventive methods and Market Trends
Market Data Forecast recently published a report on the “North America Antiviral Drugs Market” which estimates the market to grow from USD 9.91 billion from 2016 to USD 12.34 billion with a high CAGR of 4.47%. Antiviral Drugs helps in combating viral infections by hampering the replication of viruses and strengthening the immune response to the viral infection. From the past few years resistance is observed among viruses against different antiviral